Atossa Therapeutics
ATOS
#9237
Rank
NZ$0.17 B
Marketcap
NZ$1.38
Share price
5.24%
Change (1 day)
-33.29%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.38

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.40. In 2024 the company made an earnings per share (EPS) of NZ-$0.35 an increase over its 2023 EPS that were of NZ-$0.42.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.389.65%
2024NZ-$0.35-16.67%
2023NZ-$0.4214.29%
2022NZ-$0.3616.67%
2021NZ-$0.31-90.86%
2020NZ-$3.41-2.96%
2019NZ-$3.51-63.09%
2018NZ-$9.52-49.63%
2017NZ-$18.90-57.87%
2016NZ-$44.87-74.01%
2015NZ-$172.62-9.18%
2014NZ-$190.06-12.86%
2013NZ-$218.1170.73%
2012NZ-$127.7534.08%
2011NZ-$95.28263.47%
2010NZ-$26.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.07-4,638.87%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.74-4,556.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$14.96-3,856.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-8.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.52 282.61%๐Ÿ‡บ๐Ÿ‡ธ USA